918523-58-7

Basic information

• Product Name: N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide
• Synonyms: N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide;N-(2,4-Difluoro-3-forMyl)-propane-1-sulfonaMide;N-(2,4-Difluoro-3-formylphenyl)-1-propanesulfonamide;Propane-1-sulfonic acid N-(2,4-difluoro-3-formylphenyl)amide;N-(2,4-Difluoro-3-formylphenyl)-1-propanesulfonamide Propane-1-sulfonic acid N-(2,4-difluoro-3-formylphenyl)amide
• CAS NO: 918523-58-7
• Molecular Formula: C₁₀H₁₁F₂NO₃S
• Molecular Weight: 263.2610464
• Mol File: 918523-58-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 350.3±52.0 °C(Predicted)
• Appearance: /
• Density: 1.438±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 6.55±0.10(Predicted)
• CAS DataBase Reference: N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide(918523-58-7)
• EPA Substance Registry System: N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide(918523-58-7)

Safety Data

• Hazardous Substances Data: 918523-58-7(Hazardous Substances Data)

Usage

General Description

N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide, also known as DFP, is a chemical compound with the formula C9H12F2N2O2S. It is an organofluorine compound that belongs to the class of sulfonamide compounds. DFP is commonly used in the pharmaceutical industry as a potential lead compound for the development of new drugs due to its biological activity. N-(2,4-difluoro-3-formylphenyl)propane-1-sulfonamide has been studied for its potential applications in the treatment of various diseases, including cancer and bacterial infections. Its chemical structure and properties make it a promising candidate for further research and development in the field of medicinal chemistry.

Upstream product

• 918523-57-6 N-(3,5-difluorophenyl)propane-1-sulfonamide 
• 68-12-2 N,N-dimethyl-formamide 
• 4394-85-8 4-morpholinecarboxaldehyde 
• 367-25-9 2,4-difluorophenylamine 
• 1203662-90-1 2-(dimethoxymethyl)-1,3-difluoro-4-nitrobenzene 
• 1020818-16-9 3-(1,3-dioxolan-2-yl)-2,4-difluoroaniline 
• 437-81-0 2,6-difluorobenzaldehyde 
• 1103234-60-1 propane-1-sulfonic acid (2,4-difluoro-3-hydroxymethylphenyl)amide 
• 269072-20-0 3-amino-2,6-difluoro-benzoic acid ethyl ester 

Downstream Products

• 1036008-17-9 propane-1-sulfonic acid {3-[(5-cyclopentyloxy-1H-pyrrolo[2,3-b]pyridin-3-yl)-hydroxy-methyl]-2,4-difluoro-phenyl}-amide 
• 1103234-56-5 2,6-difluoro-3-(propane-1-sulfonylamino)benzoic acid 
• 1103234-60-1 propane-1-sulfonic acid (2,4-difluoro-3-hydroxymethylphenyl)amide 
• 1195070-37-1 propane-1-sulfonic acid {2,4-difluoro-3-[hydroxy-(7H-pyrrolo[2,3-d]pyrimidin-5-yl)-methyl]-phenyl}-amide 
• 1195071-58-9 propane-1-sulfonic acid {2,4-difluoro-3-[hydroxy-(4-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-methyl]-phenyl}-amide 
• 1021854-28-3 N-(3-((5-chloro-1H-pyrrolo[2,3-b]pyridine-3-yl)(hydroxyl)methyl)2,4-difluorophenyl)propane-1-sulfonamide 
• 1029872-54-5 vemurafenib 
• 1254566-59-0 5-{3-[2,6-difluoro-3-(propane-1-sulfonylamino)-benzoyl]-1H-pyrrolo[2,3-b]pyridin-5-yl}-pyridine-2-carboxylic acid ethylamide 
• 1312940-07-0 propane-1-sulfonic acid {2,4-difluoro-3-[5-(1-pyrimidin-2-yl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-phenyl}-amide 
• 1312942-05-4 N-(3-(1-(2,6-dichlorobenzoyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide 
• 1312939-70-0 propane-1-sulfonic acid {2,4-difluoro-3-[5-(1H-pyrazolo[3,4-b]pyridin-5-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-phenyl}-amide 
• 1312942-04-3 propane-1-sulfonic acid {2,4-difluoro-3-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-phenyl}-amide 
• 1312942-03-2 propane-1-sulfonic acid (2,4-difluoro-3-{hydroxy-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-methyl}-phenyl)-amide 
• 1195071-62-5 propane-1-sulfonic acid {2,4-difluoro-3-[hydroxy-(4-methoxy-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-methyl]-phenyl}-amide 

Relevant articles and documents

PROTEIN KINASE MKK4 INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH

The invention relates to pyrazolo-pyridine compounds which inhibit mitogen-activated protein kinase kinase 4 (MKK4) and in particular, selectively inhibit MKK4 over protein kinases JNK1 and MKK7. The compounds are useful for promoting liver regeneration or reducing or preventing hepatocyte death. They are further useful for treating osteoarthritis or rheumatoid arthritis, or CNS-related diseases.

Rapid, microwave-assisted organic synthesis of selective V600EBRAF inhibitors for preclinical cancer research

We report dramatically improved total syntheses of two highly selective V600EBRAF inhibitors, PLX4720 and PLX4032, that leverages microwave-assisted organic synthesis (MAOS). Compared with previously reported approaches, our novel MAOS method significantly reduces overall reaction time without compromising yield. In addition to providing a gram-scale route to these compounds for preclinical oncology research, we anticipate this approach could accelerate the synthesis of azaindoles in high-throughput, library-based formats.

PYRROLO [2, 3. B] PYRIDINES WHICH INHIBIT RAF PROTEIN KINASE

Compounds (I) and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, and forms thereof are active on each of BRaf and c-Raf -1 protein kinase, and may also be active on either or both of A-Raf and B-Raf V600E protein kinase. Also described are methods of use thereof to treat diseases and conditions, including melanoma, colorectal cancer, thyroid cancer, ovarian cancer, and biliary tract cancer.